During the past decade, Hospital Abreu Sodré - AACD conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Abreu Sodré - AACD" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator and "Mene Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Abreu Sodré - AACD" are "Amyloidosis" (2 trials), "FAP" (2 trials), "Familial Amyloid Polyneuropathy" (2 trials), "Rheumatoid Arthritis" (2 trials) and "TTR" (2 trials). Many other conditions were trialed in "Hospital Abreu Sodré - AACD" in a lesser frequency.

Most popular intervention types in "Hospital Abreu Sodré - AACD" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "GDC-0853" (2 trials), "Inotersen" (2 trials), "Adalimumab 40mg q2w" (1 trials) and "Olokizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Abreu Sodré - AACD" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Abreu Sodré - AACD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hospital Abreu Sodré - AACD, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Abreu Sodré - AACD, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".